NCT03319628 2023-11-13First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2bMersana TherapeuticsPhase 1/2 Active not recruiting523 enrolled
NCT01711970 2020-04-24A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian CancerVascular Biogenics Ltd. operating as VBL TherapeuticsPhase 1/2 Completed38 enrolled